About
Small Molecules for Dermatology & neurology
Areas of Focus
Categories
Small Molecule PharmaceuticalTaiwan
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
153
By Phase
PHASE1: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06625541Lead Sponsor
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AJ302-IM in Healthy Volunteers
PHASE1Recruiting
56 participants
Started: Jun 24, 2024 · Completed: Aug 31, 2025
NCT05517603Lead Sponsor
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients
PHASE1/PHASE2Completed
25 participants
Started: Feb 28, 2023 · Completed: Apr 8, 2024
NCT04392830Lead Sponsor
A Study to Investigate the Safety, Tolerability, Pharmacokinetics of ALZ002 DS in Healthy Volunteers
PHASE1Completed
72 participants
Started: May 11, 2020 · Completed: Jun 15, 2021
Locations (1)
Headquarters
Taipei City, Taiwan
Map
Loading map...